GR61995B - Preparation process of novel phenoxy hydroxypropylamine derivatives - Google Patents

Preparation process of novel phenoxy hydroxypropylamine derivatives

Info

Publication number
GR61995B
GR61995B GR53932A GR770153932A GR61995B GR 61995 B GR61995 B GR 61995B GR 53932 A GR53932 A GR 53932A GR 770153932 A GR770153932 A GR 770153932A GR 61995 B GR61995 B GR 61995B
Authority
GR
Greece
Prior art keywords
preparation process
novel phenoxy
hydroxypropylamine
derivatives
hydroxypropylamine derivatives
Prior art date
Application number
GR53932A
Other languages
Greek (el)
Inventor
J Teulon
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie filed Critical Hexachimie
Publication of GR61995B publication Critical patent/GR61995B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
GR53932A 1976-07-22 1977-07-09 Preparation process of novel phenoxy hydroxypropylamine derivatives GR61995B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3064776 1976-07-22
GB5357676 1976-12-22

Publications (1)

Publication Number Publication Date
GR61995B true GR61995B (en) 1979-02-14

Family

ID=26260544

Family Applications (1)

Application Number Title Priority Date Filing Date
GR53932A GR61995B (en) 1976-07-22 1977-07-09 Preparation process of novel phenoxy hydroxypropylamine derivatives

Country Status (11)

Country Link
JP (1) JPS5312851A (en)
AU (1) AU2714177A (en)
DE (1) DE2733305A1 (en)
DK (1) DK329577A (en)
ES (1) ES460866A1 (en)
FR (1) FR2359135A1 (en)
GR (1) GR61995B (en)
NL (1) NL7707949A (en)
NO (1) NO772604L (en)
PT (1) PT66781B (en)
SE (1) SE7708368L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160154U (en) * 1983-03-01 1983-10-25 セイコーエプソン株式会社 printing device
GB0319069D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Therapeutically useful compounds
JP5299810B2 (en) 2004-02-27 2013-09-25 アムジエン・インコーポレーテツド Compounds, pharmaceutical compositions and methods for use in the treatment of metabolic disorders
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
WO2007033002A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
AU2007292816B2 (en) 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
EP2139843B1 (en) 2007-04-16 2013-12-25 Amgen, Inc Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
CN102083783A (en) 2007-10-10 2011-06-01 安姆根有限公司 Substituted biphenyl GPR40 modulators
WO2009111056A1 (en) 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
CN120230084A (en) * 2023-12-28 2025-07-01 赛岚(杭州)生物医药科技有限公司 A TDG inhibitor compound and its use

Also Published As

Publication number Publication date
ES460866A1 (en) 1978-08-16
AU2714177A (en) 1979-01-25
DK329577A (en) 1978-01-23
FR2359135A1 (en) 1978-02-17
JPS5312851A (en) 1978-02-04
DE2733305A1 (en) 1978-01-26
NO772604L (en) 1978-01-24
NL7707949A (en) 1978-01-24
PT66781B (en) 1978-12-18
PT66781A (en) 1977-08-01
SE7708368L (en) 1978-01-23

Similar Documents

Publication Publication Date Title
JPS5331604A (en) Process for preparing metalacids of organicacid
HU177716B (en) Process for preparing derivatives of spiro-hydantoin
EG12406A (en) Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GR60803B (en) Preparation process of novel aryl-3-oxazlidinones-2
EG14072A (en) Process for preparing of meta-aryloxy-benzaldehydes
PT66498B (en) Process for preparation of new n-phosphonomethylglicine derivatives
GR61995B (en) Preparation process of novel phenoxy hydroxypropylamine derivatives
EG13080A (en) Process for preparing of gamma-pyrones
GR61367B (en) Preparation process of 2-benzylpyrrolidines
GR63697B (en) Process for derivatives preparation of phenyl-alamine
JPS5225783A (en) Preparation method of new phenoxy derivatives
IL51432A (en) Process for preparation of 3-halomethycephems
GR63193B (en) Preparation process of thioured derivatives
GR61990B (en) Preparation process of ((quinolyl-4)-3propyl-1)-4piperidines
GR63658B (en) Process for derivatives preparation of naphyridine
GR61183B (en) Preparation process of n-alkyldiphenylamines
GR61634B (en) Preparation process of novel aminoalcoxy-benzofurans
EG13191A (en) Process for preparing of quinoxaline-di-n-oxide derivatives
CS190339B2 (en) Process for preparing derivatives of sulphonyl-benzimidazole
GR63624B (en) Process for preparation of new aryl-alkylamine
PT67465B (en) Process for preparing of haloacylamides
CS192475B2 (en) Process for preparing derivatives of triphenylalkene
GR60349B (en) Preparation process of hydrazinopyridazine derivatives
ZA77714B (en) Process for preparation of 7-alkoxy-3-chloromethylcephems
GR62720B (en) Preparation process of novel homosteroids